glp 1 neuroprotection Neuroprotective effects of glucagon-like peptide-1 (GLP-1) analogues in epilepsy and associated comorbidities Beyond insulin: The Intriguing role

J Endocrinol 166 : 579590 Coschigano KT et al

Therapeutic landscape: current advances and translational challenges The past decade has witnessed landmark therapeutic milestones in mitochondrial medicine: Idebenone received European approval for LHON, omaveloxolone became the first FDA-approved therapy for Friedreichs ataxia in 2023, and tofersen achieved regulatory approval for SOD1-associated ALS the same year

Sunspots If you love spending time outdoors, you might have noticed small white spots on your arms, chest, or legs

how Body Pharm's batch traceability works

Other Differences Other important differences to consider are related to your personal health concerns